Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells.

Di Lorenzo B, Simões AE, Caiado F, Tieppo P, Correia DV, Carvalho T, da Silva MG, Déchanet-Merville J, Schumacher TN, Prinz I, Norell H, Ravens S, Vermijlen D, Silva-Santos B.

Cancer Immunol Res. 2019 Apr;7(4):552-558. doi: 10.1158/2326-6066.CIR-18-0647. Epub 2019 Mar 20.

PMID:
30894378
2.

Low-Density Lipoprotein Uptake Inhibits the Activation and Antitumor Functions of Human Vγ9Vδ2 T Cells.

Rodrigues NV, Correia DV, Mensurado S, Nóbrega-Pereira S, deBarros A, Kyle-Cezar F, Tutt A, Hayday AC, Norell H, Silva-Santos B, Dias S.

Cancer Immunol Res. 2018 Apr;6(4):448-457. doi: 10.1158/2326-6066.CIR-17-0327. Epub 2018 Jan 22.

3.

Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of Concept.

Almeida AR, Correia DV, Fernandes-Platzgummer A, da Silva CL, da Silva MG, Anjos DR, Silva-Santos B.

Clin Cancer Res. 2016 Dec 1;22(23):5795-5804. Epub 2016 Jun 15.

4.

Human γδ thymocytes are functionally immature and differentiate into cytotoxic type 1 effector T cells upon IL-2/IL-15 signaling.

Ribot JC, Ribeiro ST, Correia DV, Sousa AE, Silva-Santos B.

J Immunol. 2014 Mar 1;192(5):2237-43. doi: 10.4049/jimmunol.1303119. Epub 2014 Jan 31.

5.

Tumor cell recognition by γδ T lymphocytes: T-cell receptor vs. NK-cell receptors.

Correia DV, Lopes A, Silva-Santos B.

Oncoimmunology. 2013 Jan 1;2(1):e22892.

6.

Engagement of NKp30 on Vδ1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication.

Hudspeth K, Fogli M, Correia DV, Mikulak J, Roberto A, Della Bella S, Silva-Santos B, Mavilio D.

Blood. 2012 Apr 26;119(17):4013-6. doi: 10.1182/blood-2011-11-390153. Epub 2012 Mar 8.

7.

Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells.

Correia DV, Fogli M, Hudspeth K, da Silva MG, Mavilio D, Silva-Santos B.

Blood. 2011 Jul 28;118(4):992-1001. doi: 10.1182/blood-2011-02-339135. Epub 2011 Jun 1.

8.

Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells.

Gomes AQ, Correia DV, Grosso AR, Lança T, Ferreira C, Lacerda JF, Barata JT, Silva MG, Silva-Santos B.

Haematologica. 2010 Aug;95(8):1397-404. doi: 10.3324/haematol.2009.020602. Epub 2010 Mar 10.

9.

The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia/lymphoma susceptibility to gammadelta T-cell cytotoxicity.

Lança T, Correia DV, Moita CF, Raquel H, Neves-Costa A, Ferreira C, Ramalho JS, Barata JT, Moita LF, Gomes AQ, Silva-Santos B.

Blood. 2010 Mar 25;115(12):2407-11. doi: 10.1182/blood-2009-08-237123. Epub 2010 Jan 25.

10.

Inhibition of murine gammadelta lymphocyte expansion and effector function by regulatory alphabeta T cells is cell-contact-dependent and sensitive to GITR modulation.

Gonçalves-Sousa N, Ribot JC, deBarros A, Correia DV, Caramalho I, Silva-Santos B.

Eur J Immunol. 2010 Jan;40(1):61-70. doi: 10.1002/eji.200939715.

11.

Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.

Correia DV, d'Orey F, Cardoso BA, Lança T, Grosso AR, deBarros A, Martins LR, Barata JT, Silva-Santos B.

PLoS One. 2009 May 21;4(5):e5657. doi: 10.1371/journal.pone.0005657.

12.

Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance.

Gomes AQ, Correia DV, Silva-Santos B.

EMBO Rep. 2007 Nov;8(11):1024-30. Review.

Supplemental Content

Loading ...
Support Center